June 8 (Reuters) - Mendus AB (publ) IMMUN.ST :
* MENDUS ANNOUNCES DIRECTED SHARE ISSUE AND FULLY SECURED
RIGHTS
ISSUE OF UNITS TOTALING ABOUT SEK 317 MLN FINANCING
* BOARD OF DIRECTORS OF MENDUS HAS RESOLVED ON CAPITAL RAISE
OF
APPROXIMATELY SEK 317 MLN, INCLUDING DIRECTED ISSUE OF
APPROXIMATELY SEK 90 MILLION TO FLERIE
* DIRECTED ISSUE CONSISTING OF SHARES AND WARRANTS OF SERIES
TO3,
IN COMBINATION WITH A RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK
227 MLN, CONSISTING OF SHARES AND WARRANTS OF SERIES TO3
* SUBSCRIPTION PRICE IN RIGHTS ISSUE IS SEK 3.36 PER UNIT,
CORRESPONDING TO A SUBSCRIPTION PRICE OF SEK 0.48 PER SHARE
* BOD RESOLVED ON A CAPITAL RAISE OF APPROXIMATELY SEK 317.0
MLN,
COMPRISED OF DIRECTED ISSUE TO FLERIE AND RIGHTS ISSUE
* SUBSCRIPTION PERIOD IN RIGHTS ISSUE IS EXPECTED TO RUN
FROM 13
JULY 2023, UP TO AND INCLUDING 27 JULY 2023
Source text for Eikon: ID:nGNEtpwyR
Further company coverage: IMMUN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))